Last updated 15 days ago

A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)

300 patients around the world
Available in Brazil, Chile
Merck Sharp & Dohme LLC
8Research sites
300Patients around the world
This study is for people with
Leukemia
Chronic lymphocytic leukemia
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Hospital Paulistano
Recruiting
Sao Paulo, 01321-001
Centro de Pesquisas Clinicas da Fundacao Doutor Amaral Carvalho
Recruiting
Jau, 17210080
Instituto do Câncer do Estado de São Paulo "Octavio Frias de Oliveira" - ICESP
Recruiting
Av. Dr. Arnaldo, 251 - Consolação, São Paulo - SP, 01255-090, Brazil
IC La Serena Research - La Serena
Recruiting
Woodrow Wilson 1697, La Serena, Chile
James Lind Centro de Investigación del Cáncer - Temuco
Recruiting
Hochstetter 298, Temuco
Instituto Oncológico FALP - UIDO
Recruiting
José Manuel Infante 805, Providencia, Región Metropolitana
Biocenter
Recruiting
Concepción, Biobio 4070196
Centro de Estudios Clínicos SAGA - CECSAGA
Recruiting
Antonio Varas 517, 7500653 Providencia, Región Metropolitana
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy